Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT
Abattis Bioceuticals Revenue
In the fiscal year ending September 30, 2019, Abattis Bioceuticals had annual revenue of 356.88K CAD with 4,163.24% growth. Abattis Bioceuticals had revenue of 226.27K in the quarter ending September 30, 2019, with 9,064.32% growth.
Revenue
356.88K CAD
Revenue Growth
+4,163.24%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
476.00 USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |